Patents Assigned to BioPharma Works
  • Compounds for treatment of pain
    Patent number: 10072018
    Abstract: The aspects of the disclosed embodiments are directed to novel compounds, specifically, quaternary ammonium derivatives of tertiary amine containing opioid drug compounds such as hydrocodone, hydromorphone and oxycodone, formulations containing said. compounds or pharmaceutically acceptable salts thereof, which are capable of providing controlled release of the opioid drug upon administration to a patient in order to treat pain.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: September 11, 2018
    Assignee: BIOPHARMA WORKS
    Inventors: Robert Volkmann, Anthony Marfat, Peter Cornelius, Panayiotis Zagouras, Fredrick Raymond Nelson, Anton Franz Joseph Fliri
  • Metformin derivatives
    Patent number: 10017529
    Abstract: The present invention relates to novel biguanide derivatives including their pharmaceutically acceptable salts. The invention also relates processes for the preparation of, intermediates used in the preparation of, pharmaceutical compositions containing and the uses of such compounds in treating disorders such as diabetes.
    Type: Grant
    Filed: September 16, 2015
    Date of Patent: July 10, 2018
    Assignee: BioPharma Works LLC
    Inventors: Anton F Fliri, Robert A Volkmann
  • GANAXOLONE DERIVATIVES FOR TREATMENT OF CENTRAL NERVOUS SYSTEMS DISORDERS
    Publication number: 20170022245
    Abstract: The present invention is directed to Ganaxolone prodrugs with increased aqueous solubility and oral bioavailability relative to Ganaxolone and that enable development of stable extended release formulations which offer a significant therapeutic advantage and improved patience compliance by enabling treatments with lower doses over prolonged periods of time.
    Type: Application
    Filed: November 26, 2014
    Publication date: January 26, 2017
    Applicant: BioPharma Works
    Inventors: Robert A Volkmann, Anthony Marfat
  • Compounds for treatment of pain
    Patent number: 9487531
    Abstract: The invention is directed to novel compounds, formulations containing said compounds or pharmaceutically acceptable salts thereof which are suitable for administration to a patient.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: November 8, 2016
    Assignee: BioPharma Works LLC
    Inventors: Robert Volkmann, Anthony Marfat, Peter Cornelius, Panayiotis Zagouras, Frederick Raymond Nelson, Anton Franz Joseph Fliri